EFNA4 as a potential prognostic biomarker and therapeutic target for GBMLGG
Preprint in Research Square (January 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Preprint in Research Square (January 2024)
Article in Frontiers in Immunology (October 2023)
Article in Aging (July 2023)